Diagnostische Kriterien und Diagnose der Demenz vom Alzheimer-Typ

Die frühzeitige Erkennung der Alzheimer-Krankheit ist wünschenswert, kann sich jedoch oftmals schwierig gestalten. Die Diagnostik der Alzheimer-Krankheit hat in den letzten Jahren signifikante Änderungen erfahren: weg von der rein klinisch diagnostizierten Erkrankung hin zu einer biomarkergestützten Diagnose.

Schlüsselwörter

Demenztestung - neuropsychologische Untersuchung - Diagnosekriterien - Bildgebung - Laboruntersuchung - Alzheimer-Demenz

• Literatur

• 1 Beach TG, Monsell SE, Phillips LE. et al. Accuracy of the clinical diagnosis of Alzheimer disease at National Institute on Aging Alzheimer Disease Centers, 2005–2010. J Neuropathol Exp Neurol 2012; 71: 266-273
• 2 McKhann G, Drachman D, Folstein M. et al. Clinical diagnosis of Alzheimerʼs disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimerʼs Disease. Neurology 1984; 34: 939-944
• 3 Falkai P, Wittchen HU. Hrsg. Diagnostisches und Statistisches Manual psychischer Störungen DSM-5^® . Göttingen: Hogrefe; 2015
• 4 Maier W, Barnikol UB. Neurokognitive Störungen im DSM-5. Nervenarzt 2014; 85: 564-570
• 5 Jessen F, Frolich L. ICD-11: Neurokognitive Störungen. Fortschr Neurol Psychiatr 2018; 86: 172-177
• 6 Gaebel W, Jessen F, Kanba S. Neurocognitive disorders in ICD-11: the debate and its outcome. World Psychiatry 2018; 17: 229-230 doi:10.1002/wps.20534
• 7 Jack Jr CR, Bennett DA, Blennow K. et al. A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers. Neurology 2016; 87: 539-547
• 8 Dubois B, Feldman HH, Jacova C. et al. Research criteria for the diagnosis of Alzheimerʼs disease: revising the NINCDS-ADRDA criteria. Lancet Neurol 2007; 6: 734-746
• 9 Dubois B, Feldman HH, Jacova C. et al. Advancing research diagnostic criteria for Alzheimerʼs disease: the IWG-2 criteria. Lancet Neurol 2014; 13: 614-629
• 10 Dubois B, Hampel H, Feldman HH. et al. Preclinical Alzheimerʼs disease: Definition, natural history, and diagnostic criteria. Alzheimers Dement 2016; 12: 292-323
• 11 Jack jr. CR, Albert MS, Knopman DS. et al. Introduction to the recommendations from the National Institute on Aging-Alzheimerʼs Association workgroups on diagnostic guidelines for Alzheimerʼs disease. Alzheimers Dement 2011; 7: 257-262
• 12 Jack jr. CR, Bennett DA, Blennow K. et al. NIA-AA Research Framework: Toward a biological definition of Alzheimerʼs disease. Alzheimers Dement 2018; 14: 535-562
• 13 Maier W, Deuschl G. S3-Leitlinie Demenzen (2016). Im Internet: http://www.dgn.org/leitlinien/3176-leitlinie-diagnose-und-therapie-von-demenzen-2016 Stand: 04.03.2019
• 14 Harper L, Barkhof F, Fox NC. et al. Using visual rating to diagnose dementia: a critical evaluation of MRI atrophy scales. J Neurol Neurosurg Psychiat 2015; 86: 1225-1233
• 15 Scheltens P, Pasquier F, Weerts JG. et al. Qualitative assessment of cerebral atrophy on MRI: inter- and intra-observer reproducibility in dementia and normal aging. Eur Neurol 1997; 37: 95-99
• 16 Wandinger KP, Leypoldt F, Junker R. Autoantibody-mediated encephalitis. Dtsch Arztebl Int 2018; 115: 666-673
• 17 Harper L, Barkhof F, Scheltens P. et al. An algorithmic approach to structural imaging in dementia. J Neurol Neurosurg Psychiat 2014; 85: 692-698
• 18 Clarfield AM. The decreasing prevalence of reversible dementias: an updated meta-analysis. Arch Intern Med 2003; 163: 2219-2229
• 19 Jack jr. CR, Knopman DS, Jagust WJ. et al. Tracking pathophysiological processes in Alzheimerʼs disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol 2013; 12: 207-216
• 20 Lewczuk P, Riederer P, OʼBryant SE. et al. Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry. World J Biol Psychiat 2018; 19: 244-328